We’ve updated RATING30 — the rating of offers with the highest share of successful launches. The Q3 2026 analysis covers 3,370 launches: only offers with enough data (five or more launches, stable performance over ten days or more). A full review of the new rating will come out as a separate article; here we break down the dynamics: what changed versus Q2 and how to use it when choosing an offer.
The bar is higher: entry starts at 60%
In Q2, offers made it into RATING30 with a successful-launch share of 50% or more. In Q3, the minimum threshold is 60%. This isn’t a stricter selection on our side: the overall level itself has grown. More offers are being launched by affiliates consistently and with approval — competition for a spot in the top thirty is tighter.
The top of the rating changed almost completely
Not a single Q2 leader held onto a top-three position in Q3 — the upper part of the rating has been refreshed almost entirely. See the full list in your marketplace dashboard; here we’ll focus on the movement visible in the numbers.
New GEOs: Bangladesh, Ivory Coast, Panama
The most notable change of the quarter is geography. Bangladesh entered the rating with three offers at once: Livora BD (liver, 67%, $35,528), Diabend BD (diabetes, 67%), and Joint Fix BD (joints, 62%). Ivory Coast debuted with Gelules Curcuma CI (prostatitis, 60%, $16,169), and Panama with Nutricore PA (prostatitis, 67%).
Nigeria also grew: two offers in the rating, one of them the headline figure of the quarter. Posteron NG brought affiliates $107,745 — the highest revenue among all thirty RATING30 positions. Its successful-launch share is 65%: the rating is sorted by success rate, not by money, so the highest-earning offer sits below the middle of the list. The money picture is the territory of the members-only RATING50 — more on it below.
When a GEO appears in the rating for the first time, it usually means demand is already confirmed by data while competition hasn’t yet hit the ceiling.
Niches: liver debuts, joints and prostatitis hold steady
What’s new across verticals: a liver offer entered the rating for the first time — Livora BD, immediately with notable revenue. Diabetes held its positions (Diabend BD in RATING30, and in the members-only RATING50 this vertical became the densest cluster). Joints and prostatitis, as in previous quarters, form the backbone of the rating — they consistently live in the top thirty from quarter to quarter.
More launches, fewer active offers
Global figures for the quarter:
The picture reads like this: launches grew by 40%, while the number of active offers dropped noticeably. Affiliates are concentrating on a smaller pool of proven offers instead of spreading tests thin. Top-50 revenue grew by 30% — faster than the number of launches — which means not only activity is growing, but also the return per launch.
The money side: RATING50 has a new leader
The members-only RATING50 is the 50 highest-earning offers for Spirit Club residents; we don’t publish the list itself, but we’ll name two signals from it.
First: the leader has changed. In Q2, Jointex IN earned affiliates the most ($156,469); in Q3, first place went to Bone Support PH ($132,848) — Jointex IN remains in the club rating, but lower. Second: the densest money cluster of the quarter is diabetes: Diba-Care+ IN, Diabetes Solutions IN, I-Diabetic IN, Diatrust BD, Dia Amrit IN, Sugar Veda Pro IN, and one more offer from this vertical entered RATING50 with seven positions at once.
And a case visible at the intersection of the two ratings: Posteron NG. In Q2 it was in RATING30 with 50% and $94,104; in Q3 — already 65% and $107,745, plus fifth place in RATING50. The offer is growing in both launch success and revenue — the strongest possible signal.
How to use this
Three practical takeaways from the quarter’s dynamics. First: look not only at the rating itself but at its changes — an offer climbing for the second quarter in a row is more reliable than a one-time leader. Second: new GEOs in the rating are a window where demand is confirmed and competition hasn’t caught up yet. Third: offers growing in both successful-launch share and revenue are the first candidates for scaling.
A reminder: every RATING30 offer comes with a three-day guarantee — if during the first three days of your campaign the approval rate turns out below the offer’s average, we compensate the difference. The guarantee is activated through the bot.
See the full rating in your marketplace dashboard.
You may also like
GUIDES What the Marketplace Checks Before Scaling Your Offer's Volume
Why a marketplace starts at 50–100 leads per day, the four checks an offer passes before volume grows, and three actions an advertiser can take to speed up the scale-up.
GUIDES How to Read Offer Statistics: Successful Launches and Partner Revenue
Breaking down the two key metrics in an offer card — successful launch rate and partner revenue: what's behind them, what they are not, and how to read them together and over time.
RATING Shakes.pro Nutra Offer Ranking for Q3 2026
The updated RATING30 for Q3 2026: 3,370 launches analyzed, the entry threshold raised to 60%, and debuts from Bangladesh, Côte d'Ivoire and Panama.
